BenzingaAugust 13, 2026 at 8:06 AM NY2 Months Ago
HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Maintains $23 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Candel Therapeutics (NASDAQ:CADL) with a Buy and maintains $23 price target.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
